---
$id: https://graph.org.ai/products/commodity/51111634
$type: Product
source: UNSPSC
code: "51111634"
title: "Emitefur"
class: "51111600"
classTitle: "Antimetabolites"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Emitefur

**UNSPSC Code**: 51111634
**Class**: [Antimetabolites](Antimetabolites.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a pyrimidine antagonist with the molecular formula C28H19FN4O8, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9I50NF4AQ2, chemically known as m-((3-(ethoxymethyl)-5-fluoro-3,6-dihydro-2,6-dioxo-1(2h)-pyrimidinyl)carbonyl)benzoic acid, 2-ester with 2,6-dihydroxynicotinonitrile, benzoate but generally known as emitefur, which bears US NIH Compound Identifier 65910. European Medicines Agency schedules Emitefur in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06508MIG. The term EMITEFUR is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 6, No, 3 1992, List 32). EMITEFUR is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule emitefur under HS 29335995 and SITC 51576. As of Q4 2014, EMITEFUR remains the US FDA Preferred Term for this commodity. Emitefur bears US NLM identifiers UMLS ID C0053902 and NCI Concept Code C1022. SMILES: FC1CN(C(=O)N(C(=O)C2CC(CCC2)C(=O)OC2NC(OC(=O)C3CCCCC3)CCC2C#N)C1=O)COCC.

